/

Empresas

EX

No verificado

EXPERIMENTAL DRUG DEVELOPMENT CENTRE

Sobre qué escribimos

BiologíaFarmacéuticaSanidad

2 Comunicados de prensa

Ver todos los comunicados de prensa

03/06/2025

Farmacéutica

Sanidad

Biología

Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

Fuente

EXPERIMENTAL DRUG DEVELOPMENT CENTRE

Editor

1.00

0

28/05/2025

Farmacéutica

Sanidad

Biología

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

Fuente

EXPERIMENTAL DRUG DEVELOPMENT CENTRE

Editor

1.00

0

Seguidores

0

Compatibilidad

0